Oxylipins are lipid mediators produced from polyunsaturated fatty acid (PUFA) metabolism,
and are thought to be a molecular explanation for the diverse biological effects of PUFAs …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic fatty liver disease
worldwide, particularly in obese and type 2 diabetic individuals. Currently, there are no …

Lipotoxicity is a recognized pathological trigger and accelerator of nonalcoholic
steatohepatitis (NASH). However, the molecular basis of lipotoxicity-induced NASH remains …

The dysbiosis in gut microbiota could affect host metabolism and contribute to the
development of nonalcoholic fatty liver disease (NAFLD). Da-Chai-Hu decoction (DCH) has …

The unregulated oxidative modification of lipids, proteins, and nucleic acids induced by
multiple oxidants has been implicated in the pathogenesis of many diseases. Antioxidants …

Increased uptake of fat, such as through the ingestion of high fat diet (HFD), can lead to fatty
liver diseases and metabolic syndrome. It is not clear whether certain fatty acids may be …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease worldwide, particularly in obese and type 2 diabetic individuals. NAFLD ranges in …

Objective: Air pollution is associated with increased cardiovascular morbidity and mortality,
as well as dyslipidemia and metabolic syndrome. Our goal was to dissect the mechanisms …

The incidence of heart failure (HF) is generally preceded by cardiac hypertrophy (CH), which
is the enlargement of cardiac myocytes in response to stress. During CH, the metabolism of …

Arachidonic acid (AA) signaling pathway is an important constituent of inflammatory
processes. In our previous study, it was found that dihydro-stilbene gigantol relieved hepatic …